LexDanaLexDanabeta
Inventor

Yi-Qun Shi

Inventor
East Brunswick, NJ, US

Overview

63→
Patents
2000–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 63 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides16%
C07DHeterocyclic compounds10%
C12NMicroorganisms or enzymes3%
Y02ATechnologies for adaptation to climate change3%
C07BGeneral methods of organic chemistry3%
C07CAcyclic or carbocyclic compounds2%
C07HSugars2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
11,102,4382x2 array arrangement based on composite dielectric gate photosensitive detector and operating method thereof202110,822,331Processes for preparing ATR inhibitors202010,793,547Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator202010,711,039Melanocortin receptor-specific peptide with C-terminal naphthylalanine202010,632,171Melanocortin receptor-specific peptides202010,435,397Processes for preparing ATR inhibitors201910,208,027Processes for preparing ATR inhibitors201910,201,542Formulations of pyrimidinedione derivative compounds201910,195,297Iron garnet nanoparticles for cancer radiotherapy and chemotherapy201910,179,804Melanocortin receptor-specific peptides201910,112,991Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide201810,105,365Solid antiviral dosage forms201810,106,578Melanocortin-1 receptor-specific linear peptides201810,017,539Melanocortin-1 receptor-specific cyclic hexapeptides201810,000,761DNA molecule used for recombinant 20189,862,709'Processes for making compounds useful as inhibitors of ATR kinase'20189,808,543'Iron garnet nanoparticles for cancer radiotherapy and chemotherapy'20179,771,361'Inhibitors of influenza viruses replication'20179,744,170'Solid antiviral dosage forms'20179,629,841'Formulations of pyrimidinedione derivative compounds'20179,580,466'Melanocortin-1 receptor-specific linear peptides'20179,458,201'Melanocortin receptor-specific heptapeptides'20169,447,148'Melanocortin-1 receptor-specific cyclic peptides'20169,382,312'Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide'20169,333,204'Solid antiviral dosage forms'20169,040,663'Melanocortin receptor-specific peptides'20159,035,053'Processes for making compounds useful as inhibitors of ATR kinase'20158,962,633'Methods of treatment and prevention of metabolic bone diseases and disorders'20158,933,194'Melanocortin-1 receptor-specific linear peptides'20158,877,890'Melanocortin-1 receptor-specific cyclic peptides'20148,846,601'Melanocortin receptor-specific peptides'20148,729,224'Melanocortin receptor-specific peptides for treatment of female sexual dysfunction'20148,614,299'Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide'20138,492,517'Melanocortin-1 receptor-specific cyclic peptides'20138,487,073'Melanocortin receptor-specific peptides for treatment of sexual dysfunction'20138,455,618'Melanocortin receptor-specific peptides'20138,455,617'Melanocortin receptor-specific peptides'20138,263,608'Melanocortin receptor-specific spiro-piperidine compounds'20128,263,777'Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase'20128,247,530'N-alkylated cyclic peptide melanocortin agonists'20127,968,548'Melanocortin receptor-specific piperazine compounds with diamine groups'20117,964,601'Melanocortin receptor-specific compounds'20117,834,017'Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents'20107,807,678'Peptidomimetics of biologically active metallopeptides'20107,727,991'Substituted melanocortin receptor-specific single acyl piperazine compounds'20107,727,990'Melanocortin receptor-specific piperazine and keto-piperazine compounds'20107,718,802'Substituted melanocortin receptor-specific piperazine compounds'20107,709,484'Substituted melanocortin receptor-specific piperazine compounds'20107,601,753'Pyrrolidine melanocortin-specific compounds'20097,456,184'Melanocortin receptor-specific compounds'20087,432,245'Pharmaceutical formulation comprising a peptide angiogenesis inhibitor'20087,425,608'Method of making metallopeptides'20087,385,025'Metallopeptide compounds'20087,354,923'Piperazine melanocortin-specific compounds'20087,351,690'Knockout identification of target-specific sites in peptides'20087,345,144'Cyclic peptides for treatment of cachexia'20087,342,089'Cyclic peptides for treatment for cachexia'20087,326,707'Bicyclic melanocortin-specific compounds'20087,307,063'Melanocortin metallopeptides for treatment of sexual dysfunction'20077,189,755'Pyrrolidine melanocortin-specific compounds'20076,323,184'Arteriovenous and venous graft treatments: methods and compositions'20016,159,946'Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells'20006,133,242'Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2007–2020Patents assigned to PALATIN TECHNOLOGIES INC (35)· patent assignee history
2007–2020Based in East Brunswick, NJ, US· patent location history
2008–2019Based in Libertyville, IL, US· patent location history
2012–2015Patents assigned to SHI YI-QUN (8)· patent assignee history
2012–2020Patents assigned to VERTEX PHARMA (7)· patent assignee history
2012–2020Based in Natick, MA, US· patent location history
2013–2015Patents assigned to YANG WEI (6)· patent assignee history
2013–2018Based in Paris, FR· patent location history
2013–2015Based in Cranbury, NJ, US· patent location history
2016–2019Patents assigned to ABBVIE INC (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PALATIN TECHNOLOGIES INC352007–2020
SHI YI-QUNself82012–2015
VERTEX PHARMA72012–2020
YANG WEI62013–2015
ABBVIE INC52016–2019
Locations
LocationPatentsSpan
East Brunswick, New Jersey, US352007–2020
Natick, Massachusetts, US82012–2020
Libertyville, Illinois, US62008–2019
Paris, FR32013–2018
Cranbury, New Jersey, US32013–2015